基本信息
views: 474
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He has conducted multiple early phase and phase III randomised trials in the field of gastrointestinal oncology and lymphoma and is currently pursuing the development of targeted agents and immunotherapy for the treatment of these diseases.
Professor David Cunningham was awarded an OBE in the 2019 New Year Honours for services to cancer treatment and research.
Professor David Cunningham was awarded an OBE in the 2019 New Year Honours for services to cancer treatment and research.
Research Interests
Papers共 1441 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Blood Advancesno. 10 (2024): 2400-2404
crossref(2024)
crossref(2024)
crossref(2024)
EUROPEAN JOURNAL OF CANCER (2024): 114043-114043
crossref(2024)
crossref(2024)
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S209-S209
Cited0Views0Bibtex
0
0
Cancer Treatment Reviews (2024): 102789
Load More
Author Statistics
#Papers: 1451
#Citation: 114652
H-Index: 139
G-Index: 319
Sociability: 9
Diversity: 4
Activity: 207
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn